News

New method demonstrated by a team supported by NIH may help in efforts to pinpoint disease-causing genes.

The Companies combine their offerings to provide sensitive tools for interrogation specific cellular pathways via transcription factor reporters.

Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, announces that its secure mobile data capture platform, REACT CELL™, significantly improves patient retention and compliance in clinical studies.

INTEGRA Biosciences AG and Viaflo Corporation have announced that they signed agreements to combine the two companies under the name of INTEGRA Viaflo Holding AG on July 23, 2009. The new group will be active across world markets under the brand "INTEGRA". This move follows the signing of a successful strategic marketing and distribution partnership around one year previously.

Eurofins MWG Operon now offers QuickLC purification for many custom oligonucleotides to life science companies and academic research institutions in the Americas.

The workshop titled - “Assessing Suicidality in Clinical Trials and Addressing the Regulatory Directives" is to be held on 24th November 2009, in London, UK.

Scientists develop a quantitative, mathematical model of DNA replication and cell division for the bacterium Caulobacter crescentus.

JP-1730/fipamezole is a first-in-class compound, recently completed Phase II development for the treatment of Dyskinesia in Parkinson's Disease.

The study reports one-year gene therapy safety and efficacy results in treating young adults with Leber Congenital Amaurosis.

Spark Holland’s blood collection cartridges will accommodate DiLab’s automated blood sampling instrument for online solid phase extraction.